Meet our 2023 HBA Luminary award winner honored for inspiring others Meet our 2023 HBA Luminary award winner honored for inspiring others Meet our 2023 HBA Luminary award winner honored for inspiring others
new_health_insurance_marketplace_coverage_options_and_your_health_coverage.pdf new_health_insurance_marketplace_coverage_options_and_your_health_coverage.pdf
Experience our culture during your interview process Experience our culture during your interview process Discover if our company is the right fit for you.
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
We’re investing $50 million in Puerto Rico. It will increase our ability to make products to protect pets. We’re investing $50 million in Puerto Rico. It will increase our ability to make products to protect pets. We’re investing $50 million in Puerto Rico. It will increase our ability to make products to protect pets.
Boehringer Ingelheim Launches Groundbreaking Initiative “Cuida tu Don” with Entertainer “Don Francisco” Aimed at Hispanics with Type 2 Diabetes Boehringer Ingelheim Launches Groundbreaking Initiative “Cuida tu Don” with Entertainer “Don Francisco” Aimed at Hispanics with Type 2 Diabetes Boehringer Ingelheim Launches Groundbreaking Initiative “Cuida tu Don” with Entertainer “Don Francisco” Aimed at Hispanics with Type 2 Diabetes
Transboundary and Emerging Diseases | Boehringer Ingelheim US Transboundary and Emerging Diseases | Boehringer Ingelheim US Click here to find out more on how Boehringer Ingelheim fights transboundary and emerging diseases through cutting-edge technologies.
ATS Announces that BI is First Donor of COVID-19 Fund | Boehringer Ingelheim US ATS Announces that BI is First Donor of COVID-19 Fund | Boehringer Ingelheim US American Thoracic Society Announces that Boehringer Ingelheim is the first donor of its COVID‐19 Crisis Fund
Economist Impact Report: Rethinking Mental Health Care Economist Impact Report: Rethinking Mental Health Care
Prescription digital therapeutics and mental health care Prescription digital therapeutics and mental health care
Innovation in Immunology | Human Health | Boehringer Ingelheim US Innovation in Immunology | Human Health | Boehringer Ingelheim US BI's Immunology & Respiratory research combines our ability to address unmet medical needs with pioneering patient-centered approaches.
Contact Our Team | Human Health | Boehringer Ingelheim US Contact Our Team | Human Health | Boehringer Ingelheim US Find all our contact information here as well as the latest updates on where you can meet our partnering teams virtually or in person.
Boehringer Ingelheim Launches External Innovation Hub in China Boehringer Ingelheim Launches External Innovation Hub in China Boehringer Ingelheim Launches External Innovation Hub in China
When Passion Starts as a Family Value and Continues as a Work Value When Passion Starts as a Family Value and Continues as a Work Value Discover who inspires members of our LatinX Business Resource Group.
Our Culture of Caring: Volunteering Our Culture of Caring: Volunteering At BI we are committed to improving the health and well-being of people & animals. We encourage & support employee volunteer activities.